Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) Return on Invested Capital (2016 - 2025)

Utah Medical Products (UTMD) has 15 years of Return on Invested Capital data on record, last reported at 0.08% in Q3 2025.

  • For Q3 2025, Return on Invested Capital rose 8.0% year-over-year to 0.08%; the TTM value through Sep 2025 reached 0.08%, up 8.0%, while the annual FY2024 figure was 0.09%, 8.0% up from the prior year.
  • Return on Invested Capital reached 0.08% in Q3 2025 per UTMD's latest filing, down from 0.09% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.15% in Q3 2022 and bottomed at 0.0% in Q3 2024.
  • Average Return on Invested Capital over 5 years is 0.05%, with a median of 0.02% recorded in 2021.
  • Peak YoY movement for Return on Invested Capital: increased 13bps in 2021, then decreased -14bps in 2023.
  • A 5-year view of Return on Invested Capital shows it stood at 0.13% in 2021, then plummeted by -91bps to 0.01% in 2022, then fell by -12bps to 0.01% in 2023, then surged by 819bps to 0.09% in 2024, then fell by -13bps to 0.08% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 0.08% in Q3 2025, 0.09% in Q2 2025, and 0.09% in Q1 2025.